Our mission is to treat devastating diseases with intracellular therapeutics
"At Entrada, we value intellectual curiosity and enjoy the challenge of fighting the good fight: waking up each day to advance our science one step closer to helping patients and their caregivers who deserve better treatments."
Novel Platform, Growing Intracellular Therapeutics Pipeline
Our proprietary Endosomal Escape Vehicle (EEV™) Platform is highly versatile and modular, designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues with an improved therapeutic index.
Our novel approach is designed to address challenges associated with current therapeutics and engage targets previously considered inaccessible and undruggable. Explore our platform and discover our robust pipeline of discovery to clinical-stage programs.
Leadership

Dipal Doshi
Chief Executive Officer

Natarajan Sethuraman, PhD
President of Research and Development

Nathan J. Dowden
President and Chief Operating Officer

Kory Wentworth, CPA
Chief Financial Officer

Kerry Robert
Senior Vice President, People

Jared Cohen, PhD, JD
General Counsel

Karla MacDonald
Chief Corporate Affairs Officer

Kevin Healy, PhD
Senior Vice President, Regulatory Affairs
Board of Directors

Kush M. Parmar, MD, PhD
Managing Partner, 5AM Ventures (Board Chairman)

Peter S. Kim, PhD
Virginia and D.K. Ludwig Professor of Biochemistry, Stanford University

Gina Chapman
President and Chief Executive Officer, CARGO Therapeutics

Mary Thistle
Industry Leader and Independent Director

Bernhardt Zeiher, MD
Industry Leader and Independent Director

Dipal Doshi
Chief Executive Officer
Our New Podcast
Inside Entrada | Episode 1: A Fireside Chat with Dipal Doshi and Yuva Gambhir
In this first episode, we are spotlighting a fireside chat between Dipal Doshi, Chief Executive Officer, and Yuva Gambhir, a Finance and Accounting Intern who spent the summer at Entrada. While Yuva is attending the University of Pennsylvania as a cognitive science, computation and cognition major, he is also “living life to the fullest despite Duchenne muscular dystrophy.
Our Commitment to Each Other and to You
At Entrada, our approach to corporate social responsibility is built upon our collective commitment to prioritize programs that provide public benefit, advance medical treatments and improve patient outcomes. We are driven to discover, develop and commercialize life-changing medicines that are safe, effective and accessible to those who need them.
We understand that different experiences and perspectives fuel innovation. This is why we are fostering a culture and workplace environment where everyone's voice is heard, and every individual belongs. Our collective success relies on it.
Creating an organization where diversity flourishes and our employees can belong takes ongoing attention and effort – and we know we can’t do it alone. We are proud to actively partner with organizations across Boston, Cambridge and the biotech sector. They provide community and mentorship while challenging the status quo so that we can learn, grow and improve the future for all.